Cancer
Malignant Pancreatic Neoplasm
CI-CAN-00001159Explore in graph →
Top-level903 active trials8 approved drugs63 evidence items
- NCIt
- C9005
- ICD-10
- C25
- DOID
- 1793
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001159Explore in graph →
Clinical trials
3,629 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (516)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00919659 | Parenteral Nutrition Support for Patients With Pancreatic Cancer | completed | Phase 2 | 32 | CONKO-StudiengruppeOTHER | 1 | Jun 12, 2009 | clinicaltrials |
| NCT00288925 | Z-360 in Unresectable Advanced Pancreatic Cancer in Combination With Gemcitabine Treatment | completed | Phase 1 / Phase 2 | 30 | Zeria PharmaceuticalINDUSTRY | 1 | Jun 1, 2009 | clinicaltrials |
| Study of the Efficacy and Safety of Glufosfamide Compared With Best Supportive Care in Metastatic Pancreatic Cancer |
| completed |
| Phase 3 |
| 300 |
| Threshold PharmaceuticalsINDUSTRY |
| 11 |
| Apr 30, 2009 |
| clinicaltrials |
| NCT00096707 | Dose Escalation Trial of 2-Deoxy-D-Glucose (2DG) in Subjects With Advanced Solid Tumors | completed | Phase 1 | 50 | Threshold PharmaceuticalsINDUSTRY | 1 | Apr 29, 2009 | clinicaltrials |
| NCT00102700 | ARQ 501 in Combination With Gemcitabine in Subjects With Pancreatic Cancer | completed | Phase 2 | 66 | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)INDUSTRY | 1 | Apr 29, 2009 | clinicaltrials |
| NCT00234416 | IRESSA Combined With Radiotherapy & Gemcitabine as First-Line Treatment in Locally Advanced Pancreatic Cancer | completed | Phase 1 / Phase 2 | 45 | AstraZenecaINDUSTRY | 1 | Apr 23, 2009 | clinicaltrials |
| NCT00379132 | 131-I-TM-601 Study in Adults With Solid Tumors | completed | Phase 1 | 60 | TransMolecularINDUSTRY | 1 | Mar 31, 2009 | clinicaltrials |
| NCT00622622 | Gemcitabine With Antiangiogenic Peptide Vaccine Therapy in Patients With Pancreatic Cancer | completed | Phase 1 | 21 | Wakayama Medical UniversityOTHER | 1 | Feb 18, 2009 | clinicaltrials |
| NCT00252889 | Doxil Topotecan Doublet Cancer Study | completed | Phase 1 | 20 | Christiana Care Health ServicesOTHER | 1 | Jan 27, 2009 | clinicaltrials |
| NCT00338026 | A Phase I Study of ECO-4601 in Patients With Advanced Cancer | completed | Phase 1 | 26 | Thallion PharmaceuticalsINDUSTRY | 1 | Jul 15, 2008 | clinicaltrials |
| NCT00222469 | Combination Chemotherapy for 1st Line Treatment of Advanced or Metastatic Pancreatic Cancer | completed | Phase 2 | 50 | University of OklahomaOTHER | 1 | Jul 9, 2008 | clinicaltrials |
| NCT00511264 | Laparoscopic Ultrasound Guided Tissue Sampling in Patients With Cancer of the Upper Gastrointestinal Tract | completed | — | 250 | Odense University HospitalOTHER | 1 | May 29, 2008 | clinicaltrials |
| NCT00176813 | Gemcitabine, Cisplatin, and Celecoxib Treatment of Metastatic Pancreatic Cancer | completed | Phase 2 | 5 | University of Michigan Rogel Cancer CenterOTHER | 1 | May 6, 2008 | clinicaltrials |
| NCT00644618 | Randomized Controlled Trial of Gemcitabine Combined With 125I Brachytherapy | completed | Phase 3 | 120 | Huazhong University of Science and TechnologyOTHER | 0 | Mar 27, 2008 | clinicaltrials |
| NCT00005926 | Gemcitabine, Herceptin and Radiation to Treat Cancer of the Pancreas | completed | Phase 2 | 50 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00040092 | A Study to Test the Effectiveness of Virulizin® Given in Combination With Standard Chemotherapy for Pancreatic Cancer | completed | Phase 3 | 400 | Aptose Biosciences Inc.INDUSTRY | 0 | Jan 7, 2008 | clinicaltrials |
| NCT00576940 | Standard and Immunostimulating Enteral Nutrition in Surgical Patients(ImmuniEteral) | completed | Phase 4 | 196 | Jagiellonian UniversityOTHER | 1 | Dec 19, 2007 | clinicaltrials |
| NCT00558155 | The Impact of Immunostimulating Nutrition on the Outcome of Surgery | completed | Phase 4 | 214 | Jagiellonian UniversityOTHER | 1 | Nov 14, 2007 | clinicaltrials |
| NCT00536614 | Gemcitabine/Cisplatin +/-Cetuximab in Patients With Locally Advanced or Metastatic EGFR-Positive Pancreatic Cancer(SPaCe-01) | completed | Phase 2 | 86 | Gruppo Italiano per lo studio dei Carcinomi dell'Apparato DigerenteOTHER | 1 | Sep 28, 2007 | clinicaltrials |
| NCT00490373 | Trial of Pemetrexed for Patients With Pancreatic Cancer Which Cannot be Treated With Surgery or is Metastatic | completed | Phase 2 | 52 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 22, 2007 | clinicaltrials |
| NCT00055250 | A Study With LY293111, Gemcitabine and Placebo in Patients With Pancreatic Cancer | completed | Phase 2 | 130 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00245362 | A Phase II Trial of CG 8020 and CG 2505 in Patients With Nonresectable or Metastatic Pancreatic Cancer | completed | Phase 2 | 50 | Cell GenesysINDUSTRY | 1 | Oct 28, 2005 | clinicaltrials |
Data updated 23 days agoSource updated Jun 12, 2009source: clinicaltrials